中国实验诊断学
中國實驗診斷學
중국실험진단학
CHINESE JOURNAL OF LABORATORY DIAGNOSIS
2014年
8期
1262-1264
,共3页
王立波%王彦荣%席妍%李晓萌
王立波%王彥榮%席妍%李曉萌
왕립파%왕언영%석연%리효맹
mTOR%Her-2 阴性%乳腺肿瘤
mTOR%Her-2 陰性%乳腺腫瘤
mTOR%Her-2 음성%유선종류
mTOR%Her-2 nagative%breast cancer
目的:观察 mTOR 蛋白在 Her-2阴性乳腺癌中的表达,探讨其与 Her-2阴性乳腺癌发生发展相关性,为Her-2阴性乳腺癌寻找新的治疗靶点。方法采用免疫组织化学技术检测65例 Her-2阴性乳腺癌、癌旁组织及正常乳腺组织中 mTOR 的表达情况。结果 Her-2阴性乳腺癌组织中 mTOR 蛋白表达明显高于癌旁组织及正常乳腺组织,差异有统计学意义(P <0.05)。mTOR 阳性表达在腋窝淋巴结阳性组明显高于淋巴结阴性组,差异有统计学意义(P <0.05)。结论mTOR 可能与 Her-2阴性乳腺癌发生与发展相关,与腋窝淋巴结转移相关,可作为 Her-2阴性乳腺癌的预后指标及新的治疗靶点。
目的:觀察 mTOR 蛋白在 Her-2陰性乳腺癌中的錶達,探討其與 Her-2陰性乳腺癌髮生髮展相關性,為Her-2陰性乳腺癌尋找新的治療靶點。方法採用免疫組織化學技術檢測65例 Her-2陰性乳腺癌、癌徬組織及正常乳腺組織中 mTOR 的錶達情況。結果 Her-2陰性乳腺癌組織中 mTOR 蛋白錶達明顯高于癌徬組織及正常乳腺組織,差異有統計學意義(P <0.05)。mTOR 暘性錶達在腋窩淋巴結暘性組明顯高于淋巴結陰性組,差異有統計學意義(P <0.05)。結論mTOR 可能與 Her-2陰性乳腺癌髮生與髮展相關,與腋窩淋巴結轉移相關,可作為 Her-2陰性乳腺癌的預後指標及新的治療靶點。
목적:관찰 mTOR 단백재 Her-2음성유선암중적표체,탐토기여 Her-2음성유선암발생발전상관성,위Her-2음성유선암심조신적치료파점。방법채용면역조직화학기술검측65례 Her-2음성유선암、암방조직급정상유선조직중 mTOR 적표체정황。결과 Her-2음성유선암조직중 mTOR 단백표체명현고우암방조직급정상유선조직,차이유통계학의의(P <0.05)。mTOR 양성표체재액와림파결양성조명현고우림파결음성조,차이유통계학의의(P <0.05)。결론mTOR 가능여 Her-2음성유선암발생여발전상관,여액와림파결전이상관,가작위 Her-2음성유선암적예후지표급신적치료파점。
Objective We examined the expression of mTOR protein in Her-2 negative breast cancer.Discussits clin-ical significance and looks for new therapeutic target for Her-2 negative breast cancer.Methods mTOR were deter-mined immunohistochemically in 65 cases of Her-2 negative breast cancer,tumor-adjacent tissues and normal tissues. Results Positive mTOR expression was noted in Her-2 negative breast cancer apparently higher than tumor-adjacent tissues and normal tissues(P <0.05).it was also obviously higher in group with axillary lymphnode metastasis than in group with out lymphnode metastasis(P <0.05).Conclusion Expression of mTOR?significantly increased in Her-2 negative breast cancer.The detection of mTOR play an important role in tumorigenesi,it has significant correlation with axillary lymphnode metastasiss,and provide a new road for trentment of Her-2 negative breast cancer.